[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
PeptiDream Inc. shares surge due to positive updates on theranostic programs and partnerships. The company's presentations at EANM2025 and JCA2025 are driving high engagement.
PeptiDream Inc. is a Japanese biotech company focused on the discovery and development of therapeutic and diagnostic peptides.
Price 24-Hour Time-Series Raw Data
The price action is likely influenced by positive news regarding product announcements, partnerships, and financial updates, as indicated by the high engagement on related social posts. The undefined market cap and recent price fluctuations warrant caution.
1-Year High: $XXXXXXXX on 2024-12-03
1-Year Low: $XXXXX on 2025-09-04
AltRank 24-Hour Time-Series Raw Data
PeptiDream Inc. is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXXXX
1-Year High: XXXXX on 2024-11-13
1-Year Low: XXX on 2025-03-31
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-02-18
1-Year Low: XX on 2024-11-02
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXXXX +38%
6 Months: XXXXXX +183%
1 Year: XXXXXX +30%
1-Year High: XXXXXX on 2025-05-01
1-Year Low: X on 2025-01-03
Social Network | X | YouTube |
---|---|---|
Engagements | XX | XX |
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: X
6 Months: XXX +28%
1 Year: XXX +49%
1-Year High: XX on 2025-06-17
1-Year Low: X on 2024-10-18
Social Network | X | YouTube |
---|---|---|
Mentions | XX | X |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning PeptiDream Inc. in the last XX hours which is no change from in the previous XX hours
Daily Average: X
6 Months: XX +1.50%
1 Year: XX +60%
1-Year High: XX on 2025-06-17
1-Year Low: X on 2024-10-18
The most influential creators that mention PeptiDream Inc. in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@MasatoMurakami5 | X | XX | X | XX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% no change
6 Months: XXX% +20%
1 Year: XXX% no change
1-Year High: XXX% on 2025-01-16
1-Year Low: XX% on 2024-12-12
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XX | XX% | XX | XX% | X | X% |
YouTube | X | X% | XX | XX% | X | X% |
Total | XX | XX% | XX | XX% | X | X% |
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXX on 2024-12-02
1-Year Low: $XXXXXXXXXXXXXXX on 2025-02-12
Top topics mentioned In the posts about PeptiDream Inc. in the last XX hours
$pptdf, japan, barcelona, tokyo, tokyo stock exchange, over the, boston, topics, longterm, made in, $4587jp, applications, money, team and
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"PeptiDream PDRadiopharma and Curium Group Enroll First Patient to Registrational Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan #biotech #news"
X Link @BCBionetwork 2025-10-15T15:50Z 1481 followers, XX engagements
"🎯 Presentations from PeptiDream / PDRadiopharma at #EANM2025 in Barcelona successfully concluded We shared results from our CA9-targeted theranostic peptide program including first-in-human imaging data. Proud of our team and this exciting step forward in nuclear medicine"
X Link @MasatoMurakami5 2025-10-06T04:21Z XX followers, XXX engagements
"📢 At #EANM2025 in Barcelona we will present results on PeptiDreams CA9-targeted peptide: 🔹 Preclinical data 🔹 First-in-human imaging data A milestone in peptide-based theranostics. #Radiopharma #Theranostics #CA9 #PDRPharma #PeptiDream"
X Link @MasatoMurakami5 2025-10-02T21:10Z XX followers, XXX engagements
"📹We are excited to announce that we will be presenting the Group's proprietary program PD-32766 at #EANM25 this weekend PD-32766 is a peptide-based theranostic agent targeting CA9 currently under development for ccRCC. #radiopharmaceutical #theranostics #RCC #CA9 #CAIX"
X Link @PeptidreamInc 2025-10-02T02:14Z XX followers, XXX engagements